102 related articles for article (PubMed ID: 9683017)
1. A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging.
Hara T; Kusunoki M; Tsutsumi K; Okada K; Sakamoto S; Ohnaka M; Nakamura T; Miyata T; Nakayama K; Fukatsu A; Kato K; Kakumu S; Nakaya Y
Eur J Pharmacol; 1998 May; 350(1):75-9. PubMed ID: 9683017
[TBL] [Abstract][Full Text] [Related]
2. A lipoprotein lipase activator, NO-1886 prevents impaired endothelium-dependent relaxation of aorta caused by exercise in aged rats.
Kusunoki M; Tsutsumi K; Hara T; Ogawa H; Nakamura T; Miyata T; Sakakibara F; Fukuzawa Y; Suga T; Kakumu S; Nakaya Y
Exp Gerontol; 2002 Jul; 37(7):891-6. PubMed ID: 12086697
[TBL] [Abstract][Full Text] [Related]
3. Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbits.
Yin W; Tsutsumi K; Yuan Z; Yang B
Arzneimittelforschung; 2002; 52(8):610-4. PubMed ID: 12236049
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886.
Kusunoki M; Tsutsumi K; Sato D; Nakamura A; Habu S; Mori Y; Morishita M; Yonemoto T; Miyata T; Nakaya Y; Nakamura T
Eur J Pharmacol; 2011 Oct; 668(3):486-91. PubMed ID: 21835171
[TBL] [Abstract][Full Text] [Related]
5. Exercise improved accumulation of visceral fat and simultaneously impaired endothelium-dependent relaxation in old rats.
Tsutsumi K; Kusunoki M; Hara T; Okada K; Sakamoto S; Ohnaka M; Nakay Y
Biol Pharm Bull; 2001 Jan; 24(1):88-91. PubMed ID: 11201252
[TBL] [Abstract][Full Text] [Related]
6. Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Kusunoki M; Tsutsumi K; Hara T; Ogawa H; Nakamura T; Miyata T; Sakakibara F; Fukuzawa Y; Suga T; Kakumu S; Nakaya Y
Metabolism; 2002 Jun; 51(6):792-5. PubMed ID: 12037738
[TBL] [Abstract][Full Text] [Related]
7. Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: role of reactive oxygen species.
Karasu C
Eur J Pharmacol; 2000 Mar; 392(3):163-73. PubMed ID: 10762670
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats.
Kusunoki M; Tsutsumi K; Inoue Y; Hara T; Miyata T; Nakamura T; Ogawa H; Sakakibara F; Fukuzawa Y; Okabayashi N; Kato K; Ikeda H; Kurokawa T; Ishikawa T; Otake K; Nakaya Y
Metabolism; 2004 Feb; 53(2):260-3. PubMed ID: 14767881
[TBL] [Abstract][Full Text] [Related]
9. Alterations of store-operated calcium entry and cyclopiazonic acid-induced endothelium-derived relaxations in aging rat thoracic aorta.
Erac Y; Selli C; Tosun M
Physiol Int; 2016 Jun; 103(2):146-156. PubMed ID: 28639863
[TBL] [Abstract][Full Text] [Related]
10. NO-1886, a lipoprotein lipase activator, attenuates vascular smooth muscle contraction in rat aorta.
Nakamura A; Harada N; Takahashi A; Mawatari K; Nakano M; Tsutsumi K; Nakaya Y
Eur J Pharmacol; 2007 Jan; 554(2-3):183-90. PubMed ID: 17109854
[TBL] [Abstract][Full Text] [Related]
11. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet.
Kusunoki M; Hara T; Tsutsumi K; Nakamura T; Miyata T; Sakakibara F; Sakamoto S; Ogawa H; Nakaya Y; Storlien LH
Diabetologia; 2000 Jul; 43(7):875-80. PubMed ID: 10952460
[TBL] [Abstract][Full Text] [Related]
12. Effects of exercise on plasma lipoprotein levels and endothelium-dependent vasodilatation in young and old rats.
Hashimoto M
Eur J Appl Physiol Occup Physiol; 1990; 61(5-6):440-5. PubMed ID: 2079064
[TBL] [Abstract][Full Text] [Related]
13. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta.
Shinozaki K; Kashiwagi A; Nishio Y; Okamura T; Yoshida Y; Masada M; Toda N; Kikkawa R
Diabetes; 1999 Dec; 48(12):2437-45. PubMed ID: 10580434
[TBL] [Abstract][Full Text] [Related]
14. A lipoprotein lipase-promoting agent, NO-1886, improves glucose and lipid metabolism in high fat, high sucrose-fed New Zealand white rabbits.
Yin W; Yuan Z; Tsutsumi K; Xie Y; Zhang Q; Wang Z; Fu G; Long G; Yang Y
Int J Exp Diabesity Res; 2003; 4(1):27-34. PubMed ID: 12745668
[TBL] [Abstract][Full Text] [Related]
15. Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs.
Liu Y; Wang ZB; Yin WD; Li QK; Cai MB; Yu J; Li HG; Zhang C; Zu XH
Lipids Health Dis; 2011 Jul; 10():117. PubMed ID: 21762526
[TBL] [Abstract][Full Text] [Related]
16. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress.
Qian LB; Wang HP; Chen Y; Chen FX; Ma YY; Bruce IC; Xia Q
Pharmacol Res; 2010 Apr; 61(4):281-7. PubMed ID: 19892019
[TBL] [Abstract][Full Text] [Related]
17. Non-specific inhibition by human lipoproteins of endothelium dependent relaxation in rat aorta may be attributed to lipoprotein phospholipids.
Lewis TV; Dart AM; Chin-Dusting JP
Cardiovasc Res; 1997 Jun; 34(3):590-6. PubMed ID: 9231043
[TBL] [Abstract][Full Text] [Related]
18. NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats.
Kusunoki M; Tsutsumi K; Iwata K; Yin W; Nakamura T; Ogawa H; Nomura T; Mizutani K; Futenma A; Utsumi K; Miyata T
Metabolism; 2005 Dec; 54(12):1587-92. PubMed ID: 16311090
[TBL] [Abstract][Full Text] [Related]
19. The novel compound NO-1886 activates lipoprotein lipase in primary cultured adipose and skeletal muscle cells.
Hagi A; Hirai I; Kohri H; Tsutsumi K
Biol Pharm Bull; 1997 Oct; 20(10):1108-10. PubMed ID: 9353574
[TBL] [Abstract][Full Text] [Related]
20. Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator.
Ohara M; Tsutsumi K; Ohsawa N
Metabolism; 1998 Jan; 47(1):101-5. PubMed ID: 9440486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
